EONE-DIAGNOMICS Genome Center (EDGC) said Thursday that its global network would go into full operation to respond to requests for supply contracts and export of its new coronavirus diagnosis test kit.
EDGC is a genetic precision medicine company manufacturing molecular diagnostics kits through its subsidiary, Solgent. The company is negotiating with many countries for the export of several million test kits of COVID-19.
|Solgent’s new coronavirus detection kit DiaPlexQ [Credit: Solgent]|
The global demands for diagnostic kit exploded after the World Health Organization declared the current situation as a pandemic, the sixth and highest of an alert level on Wednesday. COVID-19 is WHO’s third pandemic, following the Hong Kong flu in 1968, and the swine flu in 2009.
Solgent acquired approval for the urgent of its test kit from the Korea Centers for Disease Control and Prevention on Feb. 27 and won the nod of Conformite Europeen (CE) certification for two of its products the following day. The company is operating an emergent manufacturing system to deal with surging demand
EDGC is negotiating with various countries, including the United States, Australia, Japan, China, Hong Kong, Philippines, Singapore, Vietnam, Malaysia, Bangladesh, the United Arab Emirates, Kuwait, Turkey, Kazakhstan, Germany, the United Kingdom, and Estonia.
Among the four local companies that won urgent use approval from KCDC, Solgent is the only one that makes COVID-19 diagnosis kit with self-developed raw material.
The company said it is producing the test kits by grafting its technology and know-how to its quality management, proven by ISO 9001 and ISO 13485 international certifications as well as Korea Good Manufacturing Practice.
<© Korea Biomedical Review, All rights reserved.>